Astragalus contains active compounds including astragaloside IV, cycloastragenol, and polysaccharides. Astragaloside IV has demonstrated cardioprotective and anti-inflammatory properties in animal models. Cycloastragenol activates telomerase (marketed as TA-65), though clinical anti-aging evidence remains preliminary. Astragalus polysaccharides stimulate immune cell proliferation and cytokine production.
Astragalus is immunostimulatory — directly opposes immunosuppression
May reduce lithium excretion (diuretic properties)
Theoretical antiplatelet effects
May lower blood sugar additively
Not Prohibited
Li X et al. Astragalus in cardiovascular diseases: a review.
Zhang J et al. Astragaloside IV for experimental focal cerebral ischemia.
Harley CB et al. A natural product telomerase activator (TA-65).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.